{"id":6776,"date":"2020-11-14T08:24:29","date_gmt":"2020-11-14T08:24:29","guid":{"rendered":"https:\/\/cnls.sn\/?post_type=nos_actualites&amp;p=6776"},"modified":"2020-11-14T08:24:29","modified_gmt":"2020-11-14T08:24:29","slug":"lonusida-salue-la-performance-dun-antiretroviral-injectable-pour-les-femmes","status":"publish","type":"post","link":"https:\/\/cnls.sn\/?p=6776","title":{"rendered":"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes"},"content":{"rendered":"<h2 style=\"text-align: justify;\"><span style=\"color: #ff0000;\">L&rsquo;agence de l&rsquo;ONU de lutte contre le sida<\/span> s&rsquo;est r\u00e9jouie lundi des r\u00e9sultats d&rsquo;un antir\u00e9troviral, le <span style=\"color: #ff0000;\">cabotegravir<\/span>, qui <span style=\"color: #0000ff;\">inject\u00e9 tous les deux mois permet de prot\u00e9ger les femmes contre le virus du \u00ab syndrome d&rsquo;immunod\u00e9ficience acquise<\/span> \u00bb.<\/p>\n<p>\u00ab Une<span style=\"color: #ff0000;\"> \u00e9tude<\/span> montre que les injections sont <span style=\"color: #3366ff;\">89 % plus efficaces dans la pr\u00e9vention contre le VIH<\/span> par rapport \u00e0 des pilules de <span style=\"color: #ff0000;\">prophylaxie pr\u00e9-exposition (PrEP)<\/span> prises quotidiennement \u00bb, souligne l&rsquo;agence dans un communiqu\u00e9.\/<\/p>\n<p>\u00ab <span style=\"color: #3366ff;\">Ces r\u00e9sultats sont extr\u00eamement importants<\/span>. <span style=\"color: #ff0000;\">Onusida<\/span> a longtemps r\u00e9clam\u00e9 des<span style=\"color: #3366ff;\"> moyens de pr\u00e9vention suppl\u00e9mentaires contre le VIH,<\/span> <span style=\"color: #ff0000;\">acceptables et efficaces<\/span>, pour les femmes et ceci pourrait vraiment changer la donne \u00bb, affirme <span style=\"color: #3366ff;\">Winnie Byanyima, directrice ex\u00e9cutive de Onusida.<\/span><\/p>\n<p>\u00ab Si les donateurs et les pays investissent pour <span style=\"color: #ff0000;\">distribuer des PrEP injectables aux femmes<\/span> qui courent un plus grand risque d&rsquo;infection au HIV, les <span style=\"color: #3366ff;\">nouvelles infections pourraient \u00eatre drastiquement r\u00e9duites \u00bb,<\/span> a-t-elle soulign\u00e9.<\/h2>\n<h2 style=\"text-align: justify;\">\u00ab Comme avec le<span style=\"color: #ff0000;\"> vaccin contre le Covid-19,<\/span> il nous faut maintenant <span style=\"color: #ff0000;\">nous assurer que ces injections qui peuvent sauver la vie soient disponibles,<\/span> <span style=\"color: #3366ff;\">financi\u00e8rement accessibles et \u00e9quitablement distribu\u00e9es<\/span> aux gens qui vont les utiliser \u00bb, a soulign\u00e9 <span style=\"color: #ff0000;\">Winnie Byanyima<\/span>.<\/p>\n<p>En 2018, ann\u00e9e des <span style=\"color: #3366ff;\">derni\u00e8res donn\u00e9es statistiques disponibles<\/span>, <span style=\"color: #3366ff;\">25,7 millions<\/span> de <span style=\"color: #ff0000;\">personnes vivaient avec le VIH en Afrique subsaharienne<\/span>, dont <span style=\"color: #3366ff;\">16,4 millions<\/span> b\u00e9n\u00e9ficiaient d&rsquo;un traitement antir\u00e9troviral.<\/h2>\n<h2 style=\"text-align: justify;\">\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Avec AFP<\/h2>\n","protected":false},"excerpt":{"rendered":"<p>L&rsquo;agence de l&rsquo;ONU de lutte contre le sida s&rsquo;est r\u00e9jouie lundi des r\u00e9sultats d&rsquo;un antir\u00e9troviral, le cabotegravir, qui inject\u00e9 tous les deux mois permet de prot\u00e9ger les femmes contre le virus du \u00ab syndrome d&rsquo;immunod\u00e9ficience acquise \u00bb. \u00ab Une \u00e9tude montre que les injections sont 89 % plus efficaces dans la pr\u00e9vention contre le VIH[&#8230;]\n","protected":false},"author":16,"featured_media":6777,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6776","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.3 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes - CNLS<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnls.sn\/?p=6776\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes - CNLS\" \/>\n<meta property=\"og:description\" content=\"L&rsquo;agence de l&rsquo;ONU de lutte contre le sida s&rsquo;est r\u00e9jouie lundi des r\u00e9sultats d&rsquo;un antir\u00e9troviral, le cabotegravir, qui inject\u00e9 tous les deux mois permet de prot\u00e9ger les femmes contre le virus du \u00ab syndrome d&rsquo;immunod\u00e9ficience acquise \u00bb. \u00ab Une \u00e9tude montre que les injections sont 89 % plus efficaces dans la pr\u00e9vention contre le VIH[...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnls.sn\/?p=6776\" \/>\n<meta property=\"og:site_name\" content=\"CNLS\" \/>\n<meta property=\"article:published_time\" content=\"2020-11-14T08:24:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"275\" \/>\n\t<meta property=\"og:image:height\" content=\"183\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cnls.sn\/?p=6776#article\",\"isPartOf\":{\"@id\":\"https:\/\/cnls.sn\/?p=6776\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes\",\"datePublished\":\"2020-11-14T08:24:29+00:00\",\"dateModified\":\"2020-11-14T08:24:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cnls.sn\/?p=6776\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\/\/cnls.sn\/#organization\"},\"image\":{\"@id\":\"https:\/\/cnls.sn\/?p=6776#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg\",\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cnls.sn\/?p=6776\",\"url\":\"https:\/\/cnls.sn\/?p=6776\",\"name\":\"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes - CNLS\",\"isPartOf\":{\"@id\":\"https:\/\/cnls.sn\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cnls.sn\/?p=6776#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cnls.sn\/?p=6776#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg\",\"datePublished\":\"2020-11-14T08:24:29+00:00\",\"dateModified\":\"2020-11-14T08:24:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cnls.sn\/?p=6776#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cnls.sn\/?p=6776\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/cnls.sn\/?p=6776#primaryimage\",\"url\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg\",\"contentUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg\",\"width\":275,\"height\":183,\"caption\":\"Winnie Byanyima est Directrice ex\u00e9cutive de l\u2019ONUSIDA\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cnls.sn\/?p=6776#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/cnls.sn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cnls.sn\/#website\",\"url\":\"https:\/\/cnls.sn\/\",\"name\":\"CNLS\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/cnls.sn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cnls.sn\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cnls.sn\/#organization\",\"name\":\"CNLS\",\"url\":\"https:\/\/cnls.sn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/cnls.sn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg\",\"contentUrl\":\"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg\",\"width\":814,\"height\":536,\"caption\":\"CNLS\"},\"image\":{\"@id\":\"https:\/\/cnls.sn\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/cnls.sn\/?author=16\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes - CNLS","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnls.sn\/?p=6776","og_locale":"fr_FR","og_type":"article","og_title":"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes - CNLS","og_description":"L&rsquo;agence de l&rsquo;ONU de lutte contre le sida s&rsquo;est r\u00e9jouie lundi des r\u00e9sultats d&rsquo;un antir\u00e9troviral, le cabotegravir, qui inject\u00e9 tous les deux mois permet de prot\u00e9ger les femmes contre le virus du \u00ab syndrome d&rsquo;immunod\u00e9ficience acquise \u00bb. \u00ab Une \u00e9tude montre que les injections sont 89 % plus efficaces dans la pr\u00e9vention contre le VIH[...]","og_url":"https:\/\/cnls.sn\/?p=6776","og_site_name":"CNLS","article_published_time":"2020-11-14T08:24:29+00:00","og_image":[{"width":275,"height":183,"url":"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnls.sn\/?p=6776#article","isPartOf":{"@id":"https:\/\/cnls.sn\/?p=6776"},"author":{"name":"","@id":""},"headline":"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes","datePublished":"2020-11-14T08:24:29+00:00","dateModified":"2020-11-14T08:24:29+00:00","mainEntityOfPage":{"@id":"https:\/\/cnls.sn\/?p=6776"},"wordCount":232,"publisher":{"@id":"https:\/\/cnls.sn\/#organization"},"image":{"@id":"https:\/\/cnls.sn\/?p=6776#primaryimage"},"thumbnailUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg","articleSection":["Uncategorized"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/cnls.sn\/?p=6776","url":"https:\/\/cnls.sn\/?p=6776","name":"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes - CNLS","isPartOf":{"@id":"https:\/\/cnls.sn\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnls.sn\/?p=6776#primaryimage"},"image":{"@id":"https:\/\/cnls.sn\/?p=6776#primaryimage"},"thumbnailUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg","datePublished":"2020-11-14T08:24:29+00:00","dateModified":"2020-11-14T08:24:29+00:00","breadcrumb":{"@id":"https:\/\/cnls.sn\/?p=6776#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnls.sn\/?p=6776"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cnls.sn\/?p=6776#primaryimage","url":"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg","contentUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg","width":275,"height":183,"caption":"Winnie Byanyima est Directrice ex\u00e9cutive de l\u2019ONUSIDA"},{"@type":"BreadcrumbList","@id":"https:\/\/cnls.sn\/?p=6776#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cnls.sn\/"},{"@type":"ListItem","position":2,"name":"L\u2019Onusida salue la performance d\u2019un antir\u00e9troviral injectable pour les femmes"}]},{"@type":"WebSite","@id":"https:\/\/cnls.sn\/#website","url":"https:\/\/cnls.sn\/","name":"CNLS","description":"","publisher":{"@id":"https:\/\/cnls.sn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnls.sn\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/cnls.sn\/#organization","name":"CNLS","url":"https:\/\/cnls.sn\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/cnls.sn\/#\/schema\/logo\/image\/","url":"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg","contentUrl":"https:\/\/cnls.sn\/wp-content\/uploads\/2025\/12\/Logo_Cnls_bleu_page-0001.jpg","width":814,"height":536,"caption":"CNLS"},"image":{"@id":"https:\/\/cnls.sn\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"","url":"https:\/\/cnls.sn\/?author=16"}]}},"jetpack_featured_media_url":"https:\/\/cnls.sn\/wp-content\/uploads\/2020\/11\/onusida.jpg","_links":{"self":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/posts\/6776","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/users\/16"}],"replies":[{"embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=6776"}],"version-history":[{"count":0,"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/posts\/6776\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=\/wp\/v2\/media\/6777"}],"wp:attachment":[{"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=6776"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=6776"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnls.sn\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=6776"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}